Bax D E, Amos R S
Drugs. 1986;32 Suppl 1:73-6. doi: 10.2165/00003495-198600321-00016.
The clinical outcome of rheumatoid arthritis patients treated long term with sulphasalazine or parenteral gold was studied. The rate of withdrawal from gold because of inefficacy was less frequent than that for patients receiving sulphasalazine. However, patients on sulphasalazine withdrew less frequently because of adverse reactions.
对长期使用柳氮磺胺吡啶或肠胃外金制剂治疗的类风湿性关节炎患者的临床结果进行了研究。因疗效不佳而停用金制剂的比例低于接受柳氮磺胺吡啶治疗的患者。然而，服用柳氮磺胺吡啶的患者因不良反应而停药的比例较低。
